Answers are grounded in this paper and cite their sources.
One in every four people with HIV (PWH) on dolutegravir-based ART has hypertension. We recommend the integration of hypertension management in the HIV treatment package and policies to improve existing supply chains for low cost and high-quality hypertension medications.
No takes yet. Share an insight, caveat, or question.
Mutebi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: